Insulet Corp. logo
Insulet Corp. (PODD)
Compare

Insulet Corp. (PODD) Shares Outstanding: 0.07

Is Insulet Corp.’s shares outstanding high or low?

Insulet Corp.'s shares outstanding of 0.07 is in line with its 5-year average of 0.07, near the high end of its 5-year range (0.06–0.07).

0.19% above its 12-month average of 0.07.

PODD Shares Outstanding

PODD Shares Outstanding Chart

0.07

Reported annual fiscal-period values; no daily interpolation.

+23.88% 10Y
PODD Shares Outstanding

PODD Average Shares Outstanding Chart

PODD Shares Outstanding

PODD Current vs Average Shares Outstanding Chart

PODD Shares Outstanding Metrics

SHARES OUTSTANDING

0.07

SHARES OUTSTANDING AVG TTM

0.07

SHARES OUTSTANDING AVG 3Y

0.07

SHARES OUTSTANDING AVG 5Y

0.07

SHARES OUTSTANDING AVG 10Y

0.06

SHARES OUTSTANDING AVG 15Y

0.06

SHARES OUTSTANDING AVG 20Y

0.05

CURRENT VS TTM AVG

+0.19%

CURRENT VS 3Y AVG

+0.66%

CURRENT VS 5Y AVG

+2.45%

CURRENT VS 10Y AVG

+10.09%

CURRENT VS 15Y AVG

+18.88%

CURRENT VS 20Y AVG

+30.94%

Share Structure

Shares Outstanding

70.35M

Float Shares

N/A

Stock Price

$148.88

Market Cap

$10.3B

Annual Shares Outstanding History

YearWeighted Average SharesYoY Change
202570.35M+0.39%
202470.08M+0.47%
202369.75M+0.54%
202269.38M+2.48%
202167.70M+4.58%
202064.73M+6.83%
201960.59M+2.95%
201858.86M+1.48%
201758.00M+2.32%
201656.69M-0.17%
201556.79M+2.08%
201455.63M+3.00%
201354.01M+12.70%
201247.92M+2.64%
201146.69M+17.88%
201039.61M+33.24%
200929.73M+7.66%
200827.61M+65.45%
200716.69M+1719.35%
2006917,276+200.78%
2005304,962+5.11%
2004290,140+6.62%
2003272,118-8.49%
2002297,375-

Relationship: Market Cap = Shares Outstanding × Stock Price

Key concepts:

  • Float shares: Shares available for public trading
  • Dilution: When new shares are issued, existing shareholders own less
  • Buybacks: Reduce share count, increasing EPS and ownership stake
  • Stock splits: Increase share count but don't change market cap

Insulet Corp. Shares Outstanding Formula & Definition

Shares Outstanding represents the total number of shares issued by a company that are held by all shareholders. Changes in share count affect EPS and ownership dilution.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Insulet Corp. Shares Outstanding FAQ

What is the shares outstanding for Insulet Corp. (PODD)?
The shares outstanding for PODD stock is 0.07.
Is Insulet Corp.'s shares outstanding high or low?
Insulet Corp.'s shares outstanding of 0.07 is in line with its 5-year average of 0.07, near the high end of its 5-year range (0.06–0.07).
What is the TTM average shares outstanding for Insulet Corp. (PODD)?
The TTM average shares outstanding for PODD stock is 0.07.
What is the 3Y average shares outstanding for Insulet Corp. (PODD)?
The 3Y average shares outstanding for PODD stock is 0.07.
What is the 5Y average shares outstanding for Insulet Corp. (PODD)?
The 5Y average shares outstanding for PODD stock is 0.07.
What is the 10Y average shares outstanding for Insulet Corp. (PODD)?
The 10Y average shares outstanding for PODD stock is 0.06.
What is the 15Y average shares outstanding for Insulet Corp. (PODD)?
The 15Y average shares outstanding for PODD stock is 0.06.
What is the 20Y average shares outstanding for Insulet Corp. (PODD)?
The 20Y average shares outstanding for PODD stock is 0.05.

Insulet Corp. Shares Outstanding History

DATESHARES OUTSTANDING
2025-12-310.07
2024-12-310.07
2023-12-310.07
2022-12-310.07
2021-12-310.07
2020-12-310.06
2019-12-310.06
2018-12-310.06
2017-12-310.06
2016-12-310.06
2015-12-310.06
2014-12-310.06
2013-12-310.05
2012-12-310.05
2011-12-310.05
2010-12-310.04
2009-12-310.03
2008-12-310.03
2007-12-310.02
2006-12-310.00
2005-12-310.00
2004-12-310.00
2003-12-310.00
2002-12-310.00

About Insulet Corp.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Acton, MA
5,400 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
Ashley A. McEvoy